logo
Plus   Neg
Share
Email

Fred's Posts Narrower Loss In Q2; Comps. Down 3.5% - Quick Facts

Fred's, Inc. (FRED) reported a second-quarter net loss from continuing operations of approximately $22.9 million, or $0.62 per share, compared to a net loss of $28.9 million, or $0.77 per share, for the same period in 2017.

Fred's second-quarter net sales decreased 4.3% to $419.7 million from $438.5 million, last year. Comparable store sales for the quarter decreased 3.5%. Comparable store sales were down 6.1% for the front store and down 0.5% in the retail pharmacy.

Fred's Interim CEO and CFO, Joe Anto, said, "We are continuing to make progress against our two main goals of eliminating our debt balance and returning to profitability by Q4 of this year. We recently announced an agreement with Walgreens Boots Alliance, Inc. (WBA) to sell pharmacy prescription files associated with 185 Fred's stores. This transaction should allow Fred's to almost entirely reduce the balance on our ABL Facility, allowing us to focus on returning our remaining business to profitability. We expect to close this transaction over the course of Q4."

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT